SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-021417
Filing Date
2022-05-26
Accepted
2022-05-26 16:10:35
Documents
12
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20220524.htm   iXBRL 8-K 54216
  Complete submission text file 0001564590-22-021417.txt   183319

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vktx-20220524.xsd EX-101.SCH 5629
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20220524_lab.xml EX-101.LAB 19329
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20220524_pre.xml EX-101.PRE 11516
6 EXTRACTED XBRL INSTANCE DOCUMENT vktx-8k_20220524_htm.xml XML 3562
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 22970044
SIC: 2834 Pharmaceutical Preparations